A case of suspected propofol infusion syndrome after abdominal aortic aneurysm surgery
release_vsazmtxihzgghc2oh53mwojhpq
[as of editgroup_7y6akwfmevgrxf32cgdjsjrxtq]
by
Atsushi Guntani, Ryosuke Yoshiga, Shinsuke Mii
2020 Volume 6, Issue 1, p188
Abstract
Propofol infusion syndrome (PRIS) is a rare but potentially lethal side effect during propofol administration.
The patient was scheduled for abdominal aortic aneurysm resection and reconstruction. Propofol used during sedation for ventilation after the surgery-induced rhabdomyolysis, heart failure, and renal failure. Discontinuation of propofol administration led to a dramatic improvement in the fatal symptoms, resulting in a diagnosis of PRIS.
We herein report a rare case of a PRIS during sedation in the intensive care unit after abdominal aortic aneurysm surgery. Physicians using propofol should therefore be aware of the potential risk of PRIS.
In text/plain
format
Archived Content
There are no accessible files associated with this release. You could check other releases for this work for an accessible version.
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:
2198-7793
access all versions, variants, and formats of this works (eg, pre-prints)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar